STAG2 expression loss was more common in recurrent/metastatic samples than primary samples, though this difference did not reach statistical significance (21.7% vs. 12.3%, p = 0.15).
← all excerpts
The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation.
1
0.1500
0.1500